Press releases
- Harbour BioMed Announces Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia Gravis
- HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders
- Harbour BioMed Announces IND Clearance for First-in-Class Anti-B7H7 Antibody by the U.S. FDA
Key statistics
On Friday, Hbm Holdings Ltd (2142:HKG.HZ) closed at 2.20, 152.87% above the 52 week low of 0.87 set on Nov 01, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.26 |
---|---|
High | 2.34 |
Low | 2.13 |
Bid | 2.20 |
Offer | 2.21 |
Previous close | 2.26 |
Average volume | 1.61m |
---|---|
Shares outstanding | 767.93m |
Free float | 596.03m |
P/E (TTM) | -- |
Market cap | 1.74bn HKD |
EPS (TTM) | -1.60 HKD |
Data delayed at least 15 minutes, as of Mar 24 2023 08:08 BST.
More ▼